Impact of tixagevimab/cilgavimab prophylaxis in patients undergoing allogeneic hematopoietic stem cell transplants and CAR T-cell therapy: A single center experience

Curr Res Transl Med. 2023 Jul-Sep;71(3):103402. doi: 10.1016/j.retram.2023.103402. Epub 2023 Jun 28.

¹ Hematology and Bone Marrow Transplant Unit, San Raffaele Hospital, Milan, Italy. Electronic address: xue.elisabetta@hsr.it.
² Hematology and Bone Marrow Transplant Unit, San Raffaele Hospital, Milan, Italy; Università Vita-Salute San Raffaele, Milan, Italy.
³ Hematology and Bone Marrow Transplant Unit, San Raffaele Hospital, Milan, Italy.
⁴ Hematology and Bone Marrow Transplant Unit, San Raffaele Hospital, Milan, Italy. Electronic address: corti.consuelo@hsr.it.

No abstract available

Keywords: Allogeneic hematopoietic stem cell transplant; CAR T-cell therapy; SARS-CoV-2; Tixagevimab/Cilgavimab.

Publication types